Cough differential diagnosis: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Cough}} {{CMG}}; {{AE}} {{KZ}} ==Overview== ==Cough Differential Diagnosis== {| class="wikitable" ! colspan="2" rowspan="3" style="background:#4479BA; color: #F...")
 
No edit summary
Line 49: Line 49:
* Epiglottal culture in intubated patients may show bacterial growth
* Epiglottal culture in intubated patients may show bacterial growth
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* Enlarge [[epiglottis]] (>8 mm), loss of vallecular air space and distended [[hypopharynx]] in neck [[X-rays|X-ray]]  
* Enlarge [[epiglottis]] (>8 mm), loss of vallecular air space and distended [[hypopharynx]] in neck [[X-rays|X-ray]] may be helpful
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* Normal function
* Normal function
Line 73: Line 73:
* [[Rales|Crackles]]
* [[Rales|Crackles]]
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* Low [[White blood cell count|White blood cell coun]]<nowiki/>t ([[White blood cells|WBC]]) in CBC 
* [[Leukopenia]]
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* [[Respiratory system|Subglottic]] narrowing ([[steeple sign]]) in postero-anterior [[Radiography|radiograph]] chest
* [[Respiratory system|Subglottic]] narrowing ([[steeple sign]]) in postero-anterior [[Radiography|radiograph]] chest
Line 100: Line 100:
* Serologic testing  
* Serologic testing  
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* [[Atelectasis]]
* [[Atelectasis]] may seen on chest imaging
* [[Lymphadenopathy]]
* [[Lymphadenopathy]]
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
Line 127: Line 127:
* [[Biopsy]]
* [[Biopsy]]
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* [[X-rays|X-Ray]]
* [[X-rays|X-Ray]] may be helpful
* [[Endoscopy]] examination
* [[Endoscopy]] examination may be helpful as well
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* Normal function
* Normal function
Line 200: Line 200:
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* In complicated acute [[Rhinosinusitis|bacterial rhinosinusitis]], endoscopic cultures or [[sinus]] aspirate is indicated  
* In complicated acute [[Rhinosinusitis|bacterial rhinosinusitis]], endoscopic cultures or [[sinus]] aspirate is indicated  
* Nasal culture
* Nasal culture may also be helpful
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* Air-fluid level, mucosal [[edema]] and bony erosion of sinus on [[Computed tomography|CT]]  
* Air-fluid level, mucosal [[edema]] and bony erosion of sinus on [[Computed tomography|CT]]  
Line 226: Line 226:
* [[Rhonchi]]
* [[Rhonchi]]
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* [[Eosinophilia]] is observed in [[complete blood count]] ([[Complete blood count|CBC]])
* [[Eosinophilia]]  
* Total [[serum]] [[Immunoglobulin E|IgE]] in test for [[allergy]]  
* Total [[serum]] [[Immunoglobulin E|IgE]] in test for [[allergy]] may be helpful
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* Normal [[Airway|airways]] in [[chest X-ray]]
* Normal [[Airway|airways]] in [[chest X-ray]]
Line 255: Line 255:
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* [[Sputum culture]] is not indicated
* [[Sputum culture]] is not indicated
* [[Polymerase chain reaction|PCR]] in bacterial infection
* [[Polymerase chain reaction|PCR]] in bacterial infection may be helpful
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* [[Chest X-ray]] to exclude other diseases
* [[Chest X-ray]] to exclude other diseases
Line 278: Line 278:
* [[Rhonchi]]
* [[Rhonchi]]
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* [[Blood test]]  
* [[CBC]] and [[ABG]] may be helpful 
* [[Arterial blood gas]] ([[Arterial blood gas|ABG]])
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* [[Chest X-ray|Chest X-Ray]] to exclude other diseases
* [[Chest X-ray|Chest X-Ray]] to exclude other diseases
* [[Computed tomography|CT]]
* [[Computed tomography|CT]] may also be helpful
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* [[FEV1/FVC ratio]] < 70%  
* [[FEV1/FVC ratio]] < 70%  
Line 317: Line 316:
* No response of short acting [[bronchodilator]]
* No response of short acting [[bronchodilator]]
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* [[Bronchial]] [[biopsy]] [[eosinophilia]]
* [[Bronchial]] [[biopsy]]
* [[Eosinophilia]]
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* Exposure to an occupational cause
* Exposure to an occupational cause
Line 365: Line 365:
* [[Rales|Crackles]]
* [[Rales|Crackles]]
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* [[Blood test]]
* Testing for [[alpha 1-antitrypsin]] may be helpful
* Testing for [[alpha 1-antitrypsin]]
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* [[Chest X-ray|Chest X-Ray]] to exclude other diseases
* [[Chest X-ray|Chest X-Ray]] to exclude other diseases
* [[Computed tomography|CT]]  
* [[Computed tomography|CT]] may also be helpful
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* [[FEV1/FVC ratio|FEV1/FVC]] <70%
* [[FEV1/FVC ratio|FEV1/FVC]] <70%
Line 391: Line 390:
* Decreased [[breath sounds]]  
* Decreased [[breath sounds]]  
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* No specific
* No specific tests
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* Hyperinflated lungs, [[atelectasis]], and [[mediastinitis]]
* Hyperinflated lungs, [[atelectasis]], and [[mediastinitis]]
* Shift in [[Chest X-ray|chest radiograph]] when the object is [[radio-opaque]]
* Shift in [[Chest X-ray|chest radiograph]] when the object is [[radio-opaque]]
* [[Computed tomography|CT]]
* [[Computed tomography|CT]] may be helpful
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* Not specific  
* Not specific  
Line 419: Line 418:
* Increased [[respiratory rate]]
* Increased [[respiratory rate]]
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* [[Complete blood count]] ([[CBC]])
* [[Complete blood count]] ([[CBC]]) may be helpful
* [[Urinalysis]] (in infants)
* [[Urinalysis]] & [[urine culture]] ( in infants)
* [[Urine culture]] ( in infants)
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* [[Chest X-Ray]]
* [[Chest X-Ray]] may be helpful
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* Normal function or obstructive changes ([[FEV1/FVC ratio|FEV1/FVC]] <70%)  
* Normal function or obstructive changes ([[FEV1/FVC ratio|FEV1/FVC]] <70%)  
Line 477: Line 475:
* [[Rales|Crackles]]
* [[Rales|Crackles]]
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* [[Arterial blood gas]]
* [[CBC]] and [[ABG]] may be helpful 
* [[Complete blood count]] ([[Complete blood count|CBC]])
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* Small oppacities and [[fibrosis]] observed in [[chest X-ray]]
* Small oppacities and [[fibrosis]] observed in [[chest X-ray]]
* [[Computed tomography|CT]]
* [[Computed tomography|CT]] and [[Positron emission tomography|FDG-PET]] may be helpful
* [[Positron emission tomography|FDG-PET]]
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* [[FEV1/FVC ratio|FEV1/FVC]] <70%
* [[FEV1/FVC ratio|FEV1/FVC]] <70%
Line 505: Line 501:
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* [[Hoarseness]]
* [[Hoarseness]]
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |The following investigations may be helpful:
* [[Complete blood count]] ([[Complete blood count|CBC]])
* [[Complete blood count]] ([[Complete blood count|CBC]])
* [[Alanine transaminase|ALT]], [[Aspartate transaminase|AST]]
* [[Alanine transaminase|ALT]], [[Aspartate transaminase|AST]]
Line 538: Line 534:
* [[Rales|Crackles]] or velcro rales
* [[Rales|Crackles]] or velcro rales
* [[Lung volumes|Inspiratory]] high-pitched [[rhonchi]]
* [[Lung volumes|Inspiratory]] high-pitched [[rhonchi]]
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |The following investigations may be helpful:
* Test for [[Hepatic function test|hepatic]] and [[Renal function tests|renal function]]  
* [[Hepatic function test]]  
* Hematologic test in differential [[Complete blood count|CBC]]
* [[Renal function tests|Renal function test]]  
* [[Complete blood count|CBC]]
* [[Serology|Serological testing]]
* [[Serology|Serological testing]]
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
Line 571: Line 568:
* [[Rhonchi]]
* [[Rhonchi]]
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* Sputum [[acid-fast]] bacilli ([[Acid-fast|AFB]]) smear
* Sputum [[acid-fast]] bacilli ([[Acid-fast|AFB]]) smear may be positive
* [[Mycobacterium|Mycobacterial]] [[Culture media|culture]]
* [[Mycobacterium|Mycobacterial]] [[Culture media|culture]] may be positive
* Molecular testing
* Molecular testing may be helpful
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* Reactivation of [[Tuberculosis|TB]] is observed as [[Infiltration (medical)|infiltration]] in the upper [[Lobe (anatomy)|lobe]] in [[Chest X-ray|chest X-Ray]]
* Reactivation of [[Tuberculosis|TB]] is observed as [[Infiltration (medical)|infiltration]] in the upper [[Lobe (anatomy)|lobe]] in [[Chest X-ray|chest X-Ray]]
* In patients with [[Human Immunodeficiency Virus (HIV)|HIV]], Tb is observed as lobar [[Infiltration (medical)|infiltration]], [[adenopathy]], lung mass named [[tuberculoma]], small fibronodular lesions, and/or [[pleural effusion]] [[Chest X-ray|chest X-Ray]]  
* In patients with [[Human Immunodeficiency Virus (HIV)|HIV]], Tb is observed as lobar [[Infiltration (medical)|infiltration]], [[adenopathy]], lung mass named [[tuberculoma]], small fibronodular lesions, and/or [[pleural effusion]] on [[Chest X-ray|chest X-Ray]]  
* [[Computed tomography|CT]] can detect early nodal process
* [[Computed tomography|CT]] can detect early nodal process
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
Line 601: Line 598:
* [[Tachypnea]]
* [[Tachypnea]]
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* [[Respiratory tract]] [[Culture media|culture]] for [[Cystic fibrosis|CF]]
* [[Respiratory tract]] [[Culture media|culture]] may be helpful for diagnosing secondary bacterial infection
* [[Bronchoalveolar lavage]] for cytology
* [[Bronchoalveolar lavage]] for cytology may be helpful
* ≥ 60 mmol/L [[Sweat chloride test]]
* ≥ 60 mmol/L [[Sweat chloride test]]
* [[CFTR (gene)|CFTR]] [[mutation]] in molecular testing
* [[CFTR (gene)|CFTR]] [[mutation]] in molecular testing may be positive
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* Hyperinflation, [[atelectasis]], and infiltrates on [[Chest X-ray|chest X-Ray]]
* Hyperinflation, [[atelectasis]], and infiltrates on [[Chest X-ray|chest X-Ray]]
Line 636: Line 633:
* [[Rhonchi]]
* [[Rhonchi]]
* Gurgling sounds
* Gurgling sounds
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |The following investigations may be helpful:
* [[Arterial blood gas]]
* [[Arterial blood gas]]
* [[Blood urea nitrogen|BUN]]  
* [[Blood urea nitrogen|BUN]]  
Line 671: Line 668:
* Not specifc
* Not specifc
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* [[Electrocardiogram]]
* [[Electrocardiogram]] may be helpful
* Enlargement of [[left atrium]] and [[appendage]] in [[Chest X-ray|chest radiograph]]
* Enlargement of [[left atrium]] and [[appendage]] in [[Chest X-ray|chest radiograph]]
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
Line 692: Line 689:
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* [[Dysphonia|Hoarseness]]
* [[Dysphonia|Hoarseness]]
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |The following investigations may be helpful:
* [[Human Immunodeficiency Virus (HIV)|HIV]] serology
* [[Human Immunodeficiency Virus (HIV)|HIV]] serology
* [[Anti-nuclear antibody|Antinuclear antibody]] ([[Antinuclear antibodies|ANA]])
* [[Anti-nuclear antibody|Antinuclear antibody]] ([[Antinuclear antibodies|ANA]])
Line 728: Line 725:
* Not specific
* Not specific
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* [[Upper endoscopy]]  
* [[Upper endoscopy]] may be helpful
* [[Barium]] esophagram  
* [[Barium]] esophagram may be helpful
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* Normal function
* Normal function
Line 748: Line 745:
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* [[Shortness of breath]]
* [[Shortness of breath]]
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |The following investigations may be helpful:
* [[Complete blood count]] ([[Complete blood count|CBC]])
* [[Complete blood count]] ([[Complete blood count|CBC]])
* [[Anti-neutrophil cytoplasmic antibody|ANCA]] positive
* [[Anti-neutrophil cytoplasmic antibody|ANCA]] positive
Line 754: Line 751:
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* Pulmonary infiltratation in [[Chest X-ray|chest X-Ray]]
* Pulmonary infiltratation in [[Chest X-ray|chest X-Ray]]
* [[Computed tomography|CT]] parenchimal envolment
* [[Computed tomography|CT]] scan for parenchymal involvement
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* Increased [[DLCO]]
* Increased [[DLCO]]
Line 778: Line 775:
* [[Stridor]]
* [[Stridor]]
* [[Wheeze|Wheezing]]
* [[Wheeze|Wheezing]]
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |The following investigations may be helpful:
* [[Anti-neutrophil cytoplasmic antibody|ANCA]], [[P-ANCA]], [[C-ANCA]]
* [[Anti-neutrophil cytoplasmic antibody|ANCA]], [[P-ANCA]], [[C-ANCA]]
* [[Blood urea nitrogen|BUN]]
* [[Blood urea nitrogen|BUN]]
Line 788: Line 785:
* [[Nodules]], [[Lung|pulmonary]] infiltrates, reticular margins, pleural opacities and [[Cavity|cavities]] in [[Chest X-ray|chest X-Ray]]
* [[Nodules]], [[Lung|pulmonary]] infiltrates, reticular margins, pleural opacities and [[Cavity|cavities]] in [[Chest X-ray|chest X-Ray]]
* [[Nodule (medicine)|Nodules]], [[cavities]] and stellate-shaped peripherial [[pulmonary]] in chest [[Computed tomography|CT]]
* [[Nodule (medicine)|Nodules]], [[cavities]] and stellate-shaped peripherial [[pulmonary]] in chest [[Computed tomography|CT]]
* [[Bronchoscopy]]
* [[Bronchoscopy]] may be helpful
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* Low levels of [[DLCO]]
* Low levels of [[DLCO]]
Line 811: Line 808:
* [[Wheeze|Wheezing]]
* [[Wheeze|Wheezing]]
* Squeaky sounds
* Squeaky sounds
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |The following investigations may be helpful:
* [[Complete blood count]] ([[CBC]])
* [[Complete blood count]] ([[CBC]])
* [[Urinalysis]]
* [[Urinalysis]]
Line 848: Line 845:
* [[Stridor]]
* [[Stridor]]
* [[Wheeze|Wheezing]]
* [[Wheeze|Wheezing]]
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |The following investigations may be helpful:
* [[ANCA]] positive
* [[ANCA]] positive
* [[Blood urea nitrogen|BUN]]
* [[Blood urea nitrogen|BUN]]
Line 856: Line 853:
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* [[Cavitation]], [[Nodule (medicine)|nodules]], and alveolar opacities in [[chest X-ray]]
* [[Cavitation]], [[Nodule (medicine)|nodules]], and alveolar opacities in [[chest X-ray]]
* Head and chest [[Computed tomography|CT]]
* Head and chest [[Computed tomography|CT]] may be helpful
* [[Electromyography]]/[[nerve conduction study]]
* [[Electromyography]]/[[nerve conduction study]] may also be helpful
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* Reduced [[lung volumes]]
* Reduced [[lung volumes]]
Line 884: Line 881:
* Peripherial [[eosinophilia]]
* Peripherial [[eosinophilia]]
* In active phase [[C-reactive protein|CRP]] and [[Red blood cell|erytrocyte]] [[sedimentation]] rate high  
* In active phase [[C-reactive protein|CRP]] and [[Red blood cell|erytrocyte]] [[sedimentation]] rate high  
* High levels of [[Immunoglobulin E|IgE]]
* Elevated [[Immunoglobulin E|IgE]]
* [[Anti-neutrophil cytoplasmic antibody|ANCA]] positive
* [[Anti-neutrophil cytoplasmic antibody|ANCA]] positive
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
Line 913: Line 910:
* [[Wheeze|Wheezing]]
* [[Wheeze|Wheezing]]
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* Not  required
* Not  indicated
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* No required
* No indicated
| style="background:#F5F5F5;" + |
| style="background:#F5F5F5;" + |
* Normal function
* Normal function
Line 924: Line 921:
*[[Angioedema]]
*[[Angioedema]]
|}
|}
<references />

Revision as of 14:58, 5 March 2018

Cough Microchapters

Home

Patient Information

Overview

Classification

Historical perspective

Pathophysiology

Causes

Differentiating Cough from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cough differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cough differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cough differential diagnosis

CDC on Cough differential diagnosis

Cough differential diagnosis in the news

Blogs on Cough differential diagnosis

Directions to Hospitals Treating Cough

Risk calculators and risk factors for Cough differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Karina Zavaleta, MD [2]

Overview

Cough Differential Diagnosis

Organ system Diseases Clinical manifestations Diagnosis Other features
Symptoms Physical exam
Onset Duration Productive cough Hemoptysis Weight lost Fever Dyspnea Ascultation Lab findings Imaging PFT Gold standard
Respiratory Upper airway diseases Epiglottitis[1][2] Abrupt or acute
  • 12-24 hours
- - -
  • Elevated white blood count in CBC
  • Blood culture may show bacterial growth
  • Epiglottal culture in intubated patients may show bacterial growth
  • Normal function
Croup[3] Acute
  • 3-5 days
- - -
  • Clinical diagnosis.
  • Laboratory findings and imaging are not necessary for diagnosis
Pertussis[4][5] Acute
  • Two weeks
✔ Whooping sound - -
  • Clear chest
  • Normal function
  • Culture
Laryngopharyngeal reflux[6][7] Chronic
  • Variable
- - -
  • Normal function
  • 24 hour-dual sensor pH probe
Common Cold[8] Acute
  • 3-10 days
- - -
  • Bacterial culture is not indicated
  • Normal function
  • Clinical diagnosis
Seasonal Influenza [9] Acute
  • 5-10 days
- - -
  • Normal function
  • Clinical diagnosis
Rhinosinusitis[10][11] Acute, subacute, chronic, recurrent
  • Acute: Less than 4 weeks
  • Subacute: 4-12 weeks
  • Chronic: More than 12 weeks
  • Recurrent: 4 or more episodes or acute rhinosinusitis per year
- -
  • Clear chest
  • Air-fluid level, mucosal edema and bony erosion of sinus on CT
  • MRI for distinguish the etiology
  • Normal function
Lower airway Asthma[12] Chronic
  • Years
✔ Clear mucoid or yellow sputum - - -
  • Family history
  • Seasonal variation
Acute Bronchitis[13] Acute
  • From 5 days to 1 or 3 weeks
- - -
  • FEV1 < 80%
  • Clinical diagnosis
Chronic Bronchitis[14][15] Chronic
  • Most of the days for three months in the las two years.
✔ Clear sputum - -
Non-asthmatic eosinophilic bronchitis[16][17] Chronic
  • More than 8 weeks
Eosinophilic sputum - -
  • Exposure to an occupational cause
Bronchiectasis[18] Chronic
  • Months to years
✔ Mucopurulent sputum -
  • CT of chest
Emphysema [19] Chronic
  • Months to years
✔ Mucoid or purulent sputum - -
  • Exposure of tobacco and air pollution
Foreing body aspiration[20][21][22] Acute
  • Variable
-
  • No specific tests
  • Not specific
  • In children <1 year and adults >75 years
  • Organic materials in children
  • Inorganic materials in adults
Bronchiolitis[23][24] Acute
  • 8-15 days
-
  • Clinical diagnosis
Parenchyma Pneumonia[25][26] Acute
  • Variable
✔ Mucopurulent sputum - -
  • Not specific
Pneumoconioses[27][28] Acute, Chronic
  • Years
- -
Lung cancer[29][30] Chronic
  • Years
- The following investigations may be helpful:
  • Not specific
Interstitial lung disease[31][32] Chronic
  • Variable
- - The following investigations may be helpful:
  • Lung biopsy when lab, imaging, and PFT has indeterminate result
Tuberculosis (TB)[33][34] Chronic
  • More than 2 or 3 weeks
Cystic fibrosis (CF)[35][36] Chronic
  • Variable
-
  • Evidence of CFTR dysfunction
Cardiac Cardiogenic pulmonary edema[37][38] Acute
  • Days to weeks
✔ Pink frothy, liquid - - The following investigations may be helpful:
  • Not specific
  • Clinical diagnosis
  • Tests are supportive
Mitral Stenosis[39][40] Chronic
  • Variable
✔ Pink frothy - -
  • Not specifc
Pulmonary hypertension[41][42] Chronic
  • More than 2 years
- - The following investigations may be helpful:
Gastrointestinal Gastroesophageal reflux[43][44] Chronic
  • Variable
- -
  • Not specific
  • Normal function
  • PH testing
--
Autoinmune Goodpasture syndrome[45][46] Chronic
  • Variable
- - - The following investigations may be helpful:
  • Pulmonary infiltratation in chest X-Ray
  • CT scan for parenchymal involvement
Wegener's disease (GPA) [47][48] Chronic
  • Months
The following investigations may be helpful:
Sarcoidosis[49][50] Chronic
  • Years
- - The following investigations may be helpful:
Microscopic polyangitis (MPA)[51] Chronic
  • Variable
The following investigations may be helpful:
Churg-Strauss[52][53] Chronic
  • Variable
  • Infiltrates in chest X-Ray
  • Ground glass opacities, tree-in-bud sign and small nodules in chest CT
Medication ACE inhibitors[54][55] Acute (depend on the medication)
  • From 2 weeks to 6 months
- - - -
  • Not indicated
  • No indicated
  • Normal function
  • Clinical diagnosis
  • Resolves in four to five days of stopping the medication
  • Angioedema
  1. Stroud RH, Friedman NR (2001). "An update on inflammatory disorders of the pediatric airway: epiglottitis, croup, and tracheitis". Am J Otolaryngol. 22 (4): 268–75. doi:10.1053/ajot.2001.24825. PMID 11464324.
  2. Solomon P, Weisbrod M, Irish JC, Gullane PJ (1998). "Adult epiglottitis: the Toronto Hospital experience". J Otolaryngol. 27 (6): 332–6. PMID 9857318.
  3. Cherry, James D. (2008). "Croup". New England Journal of Medicine. 358 (4): 384–391. doi:10.1056/NEJMcp072022. ISSN 0028-4793.
  4. Bellamy EA, Johnston ID, Wilson AG (1987). "The chest radiograph in whooping cough". Clin Radiol. 38 (1): 39–43. PMID 3816065.
  5. "Pertussis | Whooping Cough | Clinical | Information | CDC".
  6. "What is LPR? | American Academy of Otolaryngology-Head and Neck Surgery".
  7. Noordzij JP, Khidr A, Desper E, Meek RB, Reibel JF, Levine PA (2002). "Correlation of pH probe-measured laryngopharyngeal reflux with symptoms and signs of reflux laryngitis". Laryngoscope. 112 (12): 2192–5. doi:10.1097/00005537-200212000-00013. PMID 12461340.
  8. Eccles R (2005). "Understanding the symptoms of the common cold and influenza". Lancet Infect Dis. 5 (11): 718–25. doi:10.1016/S1473-3099(05)70270-X. PMID 16253889.
  9. Kim EA, Lee KS, Primack SL, Yoon HK, Byun HS, Kim TS, Suh GY, Kwon OJ, Han J (2002). "Viral pneumonias in adults: radiologic and pathologic findings". Radiographics. 22 Spec No: S137–49. doi:10.1148/radiographics.22.suppl_1.g02oc15s137. PMID 12376607.
  10. Meltzer EO, Hamilos DL (2011). "Rhinosinusitis diagnosis and management for the clinician: a synopsis of recent consensus guidelines". Mayo Clin Proc. 86 (5): 427–43. doi:10.4065/mcp.2010.0392. PMC 3084646. PMID 21490181.
  11. Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, Brook I, Ashok Kumar K, Kramper M, Orlandi RR, Palmer JN, Patel ZM, Peters A, Walsh SA, Corrigan MD (2015). "Clinical practice guideline (update): adult sinusitis". Otolaryngol Head Neck Surg. 152 (2 Suppl): S1–S39. doi:10.1177/0194599815572097. PMID 25832968.
  12. Ukena D, Fishman L, Niebling WB (2008). "Bronchial asthma: diagnosis and long-term treatment in adults". Dtsch Arztebl Int. 105 (21): 385–94. doi:10.3238/arztebl.2008.0385. PMC 2696883. PMID 19626179.
  13. Wenzel RP, Fowler AA (2006). "Clinical practice. Acute bronchitis". N. Engl. J. Med. 355 (20): 2125–30. doi:10.1056/NEJMcp061493. PMID 17108344.
  14. Brusasco V, Martinez F (2014). "Chronic obstructive pulmonary disease". Compr Physiol. 4 (1): 1–31. doi:10.1002/cphy.c110037. PMID 24692133.
  15. Qaseem A, Snow V, Shekelle P, Sherif K, Wilt TJ, Weinberger S, Owens DK (2007). "Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians". Ann. Intern. Med. 147 (9): 633–8. PMID 17975186.
  16. Brightling CE (2006). "Chronic cough due to nonasthmatic eosinophilic bronchitis: ACCP evidence-based clinical practice guidelines". Chest. 129 (1 Suppl): 116S–121S. doi:10.1378/chest.129.1_suppl.116S. PMID 16428700.
  17. Cho J, Choi SM, Lee J, Park YS, Lee SM, Yoo CG; et al. (2018). "Clinical Outcome of Eosinophilic Airway Inflammation in Chronic Airway Diseases Including Nonasthmatic Eosinophilic Bronchitis". Sci Rep. 8 (1): 146. doi:10.1038/s41598-017-18265-2. PMC 5760521. PMID 29317659.
  18. King PT, Holdsworth SR, Freezer NJ, Villanueva E, Holmes PW (2006). "Characterisation of the onset and presenting clinical features of adult bronchiectasis". Respir Med. 100 (12): 2183–9. doi:10.1016/j.rmed.2006.03.012. PMID 16650970.
  19. Rossi A, Butorac-Petanjek B, Chilosi M, Cosío BG, Flezar M, Koulouris N; et al. (2017). "Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies". Int J Chron Obstruct Pulmon Dis. 12: 2593–2610. doi:10.2147/COPD.S132236. PMC 5587130. PMID 28919728.
  20. Hewlett JC, Rickman OB, Lentz RJ, Prakash UB, Maldonado F (2017). "Foreign body aspiration in adult airways: therapeutic approach". J Thorac Dis. 9 (9): 3398–3409. doi:10.21037/jtd.2017.06.137. PMC 5708401. PMID 29221325.
  21. Rafanan AL, Mehta AC (2001). "Adult airway foreign body removal. What's new?". Clin. Chest Med. 22 (2): 319–30. PMID 11444115.
  22. Haddadi S, Marzban S, Nemati S, Ranjbar Kiakelayeh S, Parvizi A, Heidarzadeh A (2015). "Tracheobronchial Foreign-Bodies in Children; A 7 Year Retrospective Study". Iran J Otorhinolaryngol. 27 (82): 377–85. PMC 4639691. PMID 26568942.
  23. Bordley WC, Viswanathan M, King VJ, Sutton SF, Jackman AM, Sterling L, Lohr KN (2004). "Diagnosis and testing in bronchiolitis: a systematic review". Arch Pediatr Adolesc Med. 158 (2): 119–26. doi:10.1001/archpedi.158.2.119. PMID 14757603.
  24. "www.nice.org.uk".
  25. Bartlett JG, Dowell SF, Mandell LA, File Jr TM, Musher DM, Fine MJ (2000). "Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America". Clin. Infect. Dis. 31 (2): 347–82. doi:10.1086/313954. PMID 10987697.
  26. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM, Musher DM, Niederman MS, Torres A, Whitney CG (2007). "Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults". Clin. Infect. Dis. 44 Suppl 2: S27–72. doi:10.1086/511159. PMID 17278083.
  27. Jp NA, Imanaka M, Suganuma N (2017). "Japanese workplace health management in pneumoconiosis prevention". J Occup Health. 59 (2): 91–103. doi:10.1539/joh.16-0031-RA. PMC 5478517. PMID 27980247.
  28. Weiland DA, Lynch DA, Jensen SP, Newell JD, Miller DE, Crausman RS, Kuhn C, Kern DG (2003). "Thin-section CT findings in flock worker's lung, a work-related interstitial lung disease". Radiology. 227 (1): 222–31. doi:10.1148/radiol.2271011063. PMID 12668748.
  29. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011). "Global cancer statistics". CA Cancer J Clin. 61 (2): 69–90. doi:10.3322/caac.20107. PMID 21296855.
  30. Ost DE, Jim Yeung SC, Tanoue LT, Gould MK (2013). "Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines". Chest. 143 (5 Suppl): e121S–e141S. doi:10.1378/chest.12-2352. PMC 4694609. PMID 23649435.
  31. Lama VN, Martinez FJ (2004). "Resting and exercise physiology in interstitial lung diseases". Clin. Chest Med. 25 (3): 435–53, v. doi:10.1016/j.ccm.2004.05.005. PMID 15331185.
  32. Chetta A, Marangio E, Olivieri D (2004). "Pulmonary function testing in interstitial lung diseases". Respiration. 71 (3): 209–13. doi:10.1159/000077416. PMID 15133338.
  33. Perlman DC, el-Sadr WM, Nelson ET, Matts JP, Telzak EE, Salomon N, Chirgwin K, Hafner R (1997). "Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG)". Clin. Infect. Dis. 25 (2): 242–6. PMID 9332519.
  34. Barnes PF, Verdegem TD, Vachon LA, Leedom JM, Overturf GD (1988). "Chest roentgenogram in pulmonary tuberculosis. New data on an old test". Chest. 94 (2): 316–20. PMID 2456183.
  35. Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, Durie PR, Legrys VA, Massie J, Parad RB, Rock MJ, Campbell PW (2008). "Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report". J. Pediatr. 153 (2): S4–S14. doi:10.1016/j.jpeds.2008.05.005. PMC 2810958. PMID 18639722.
  36. Kerem E, Reisman J, Corey M, Canny GJ, Levison H (1992). "Prediction of mortality in patients with cystic fibrosis". N. Engl. J. Med. 326 (18): 1187–91. doi:10.1056/NEJM199204303261804. PMID 1285737.
  37. Gheorghiade M, Zannad F, Sopko G, Klein L, Piña IL, Konstam MA, Massie BM, Roland E, Targum S, Collins SP, Filippatos G, Tavazzi L (2005). "Acute heart failure syndromes: current state and framework for future research". Circulation. 112 (25): 3958–68. doi:10.1161/CIRCULATIONAHA.105.590091. PMID 16365214.
  38. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL (2013). "2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines". Circulation. 128 (16): e240–327. doi:10.1161/CIR.0b013e31829e8776. PMID 23741058.
  39. MUNROE DS, RALLY CR (1963). "The diagnosis of mitral stenosis". Can Med Assoc J. 88: 611–22. PMC 1921207. PMID 13936649.
  40. Chandrashekhar Y, Westaby S, Narula J (2009). "Mitral stenosis". Lancet. 374 (9697): 1271–83. doi:10.1016/S0140-6736(09)60994-6. PMID 19747723.
  41. Brown LM, Chen H, Halpern S, Taichman D, McGoon MD, Farber HW, Frost AE, Liou TG, Turner M, Feldkircher K, Miller DP, Elliott CG (2011). "Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry". Chest. 140 (1): 19–26. doi:10.1378/chest.10-1166. PMC 3198486. PMID 21393391.
  42. Sun XG, Hansen JE, Oudiz RJ, Wasserman K (2003). "Pulmonary function in primary pulmonary hypertension". J Am Coll Cardiol. 41 (6): 1028–35. PMID 12651053.
  43. Kahrilas PJ, Hughes N, Howden CW (2011). "Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease". Gut. 60 (11): 1473–8. doi:10.1136/gut.2011.241307. PMID 21508423.
  44. Badillo R, Francis D (2014). "Diagnosis and treatment of gastroesophageal reflux disease". World J Gastrointest Pharmacol Ther. 5 (3): 105–12. doi:10.4292/wjgpt.v5.i3.105. PMC 4133436. PMID 25133039.
  45. Boyce NW, Holdsworth SR (1986). "Pulmonary manifestations of the clinical syndrome of acute glomerulonephritis and lung hemorrhage". Am. J. Kidney Dis. 8 (1): 31–6. PMID 3728460.
  46. Foster MH (2017). "Basement membranes and autoimmune diseases". Matrix Biol. 57-58: 149–168. doi:10.1016/j.matbio.2016.07.008. PMC 5290253. PMID 27496347.
  47. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS (1992). "Wegener granulomatosis: an analysis of 158 patients". Ann. Intern. Med. 116 (6): 488–98. PMID 1739240.
  48. Falk RJ, Gross WL, Guillevin L, Hoffman GS, Jayne DR, Jennette JC, Kallenberg CG, Luqmani R, Mahr AD, Matteson EL, Merkel PA, Specks U, Watts RA (2011). "Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis". Arthritis Rheum. 63 (4): 863–4. doi:10.1002/art.30286. PMID 21374588.
  49. Carmona EM, Kalra S, Ryu JH (2016). "Pulmonary Sarcoidosis: Diagnosis and Treatment". Mayo Clin. Proc. 91 (7): 946–54. doi:10.1016/j.mayocp.2016.03.004. PMID 27378039.
  50. Yanardağ H, Pamuk GE, Karayel T, Demirci S (2002). "Bone marrow involvement in sarcoidosis: an analysis of 50 bone marrow samples". Haematologia (Budap). 32 (4): 419–25. PMID 12803116.
  51. Jennette, J. Charles; Falk, Ronald J. (1997). "Small-Vessel Vasculitis". New England Journal of Medicine. 337 (21): 1512–1523. doi:10.1056/NEJM199711203372106. ISSN 0028-4793.
  52. Vaglio A, Buzio C, Zwerina J (2013). "Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art". Allergy. 68 (3): 261–73. doi:10.1111/all.12088. PMID 23330816.
  53. Lanham JG, Elkon KB, Pusey CD, Hughes GR (1984). "Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome". Medicine (Baltimore). 63 (2): 65–81. PMID 6366453.
  54. Israili ZH, Hall WD (1992). "Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology". Ann. Intern. Med. 117 (3): 234–42. PMID 1616218.
  55. Wood R (1995). "Bronchospasm and cough as adverse reactions to the ACE inhibitors captopril, enalapril and lisinopril. A controlled retrospective cohort study". Br J Clin Pharmacol. 39 (3): 265–70. PMC 1365002. PMID 7619667.